Due to UACR variability, repeat testing may be necessary for clinical monitoring of patients with type 2 diabetes. The urinary albumin-to-creatinine ratio (UACR) can vary widely within individuals ...

The FDA has granted Priority Review to finerenone (Kerendia) for adults with type 1 diabetes and CKD, following FINE-ONE trial data showing a 25% reduction in UACR.

Early albuminuria reduction with finerenone (Kerendia) drove protection against chronic kidney disease (CKD) progression in people with type 2 diabetes, according to a post-hoc mediation analysis. At ...

Please provide your email address to receive an email when new articles are posted on . UACR had stronger associations than UPCR for children with moderate to severe proteinuria and albuminuria. Both ...

"In CONFIDENCE, 70% of patients on both therapies achieved the ADA-recommended UACR reduction target of >30%. Since UACR is a key mediator of kidney and cardiovascular outcomes, these results are ...

Marc P. Bonaca, MD, MPH, and Josephine Harrington, MD, discuss the clinical value of the uACR test and why it remains underutilized. Chronic kidney disease (CKD) affects an estimated 37 million ...

Please provide your email address to receive an email when new articles are posted on . Reduction of albuminuria benefited patients with CKD, type 2 diabetes. Patients who had 30% or greater reduction ...

For patients with rheumatoid arthritis (RA), urine albumin-to-creatinine ratio (ACR) is an independent risk factor indicating prognosis, according to a study published online Sept. 18 in Frontiers in ...

Reducing the urine albumin-to-creatinine ratio (UACR) significantly reduces kidney risk in people with type 2 diabetes, per new research in the Annals of Internal Medicine. Post hoc retrospective ...

A patient-level meta-analysis found urinary albumin-creatinine ratio was a slightly stronger predictor of kidney failure than urinary protein-creatinine ratio, especially in patients with high-risk ...